Fourth Quarter and Full Year 2025 Earnings Presentation costs; and • fluctuations in the amount and frequency of repurchases of our common stock. February 27, 2026 1 Forward-Looking Statements; Non-GAAP Financial Information Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial per ...

Amneal Pharmaceuticals Q4 2025 Earnings Call Cautionary statement on forward looking statements Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Such forward-looking statements include statements regarding management's intentions, plans, beliefs, expectations, financial results, or forecasts for the future, including among other things: discussions of future opera ...

Fourth Quarter 2025 Presentation of Financial Results February 27, 2026 Find, mine and deliver the planet's most important and essential minerals that enable the world and humankind to create, innovate, and prosper. F e b r u a r y 2 0 2 6 Forward-Looking Information NASDAQ: AUGO| B3:AURA33 Operational Performance and Highlights Fourth Quarter 2025 Results This presentation contains "forward-looking information" and "forward-looking statements", as defined in applicable securities laws (collectively, "forwa ...

Investor Presentation February 27, 2026 Founded in 2011 | Located in El Monte, CA | NASDAQ:FLGT Disclaimer Forward-Looking Statements and Market Data This presentation contains forward-looking statements, which are statements other than those of historical facts and which represent the estimates and expectations of Fulgent Genetics, Inc. (the "Company" or "Fulgent") about future events based on current views and assumptions. Examples of forward-looking statements made in this presentation include, among oth ...

Equity Investor Presentation December 31, 2025 Forward-Looking Statements and Safe Harbor Disclosure 2 ASSURED GUARANTY LTD. • This presentation contains information that includes or is based upon forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward looking statements give the expectations or forecasts of future events of Assured Guaranty Ltd. (AGL) and its subsidiaries (collectively with AGL, Assured Guaranty or the Company). These statements can be ...

Supplemental Information Fourth Quarter 2025 Disclaimers IN GENERAL . Thisdisclaimerapplies tothisdocumentand theverbal or writtencommentsof any personpresentingit. Thisdocument,takentogetherwithany suchverbal or writtencomments,is referredtohereinas the "Presentation." Theinformationcontainedon, or accessible through,any websitesincludedin thisPresentationis notincorporatedby referenceinto,and shouldnotbe considereda partof, thisPresentation. FORWARD -LOOKING STATEMENTS . Certainstatementsin thisPresentati ...

Bain Capital Specialty Finance, Inc. Fourth Quarter Ended December 31, 2025 Earnings Presentation DISCLAIMER PLEASE CONSIDER THE FOLLOWING In this material Bain Capital Credit, LP, Bain Capital Credit (Australia), Pty. Ltd., Bain Capital Credit, Ltd., Bain Capital Investments (Europe) Limited, Bain Capital Investments (Ireland) Limited, Bain Capital Credit CLO Advisors, LP, Bain Capital Credit U.S. CLO Manager, LLC, Bain Capital Credit U.S. CLO Manager II, LP, Bain Capital Credit (Asia) Limited, Bain Capita ...

February 2026 Investor Presentation Note: All financials presented are in US$ unless otherwise noted. Disclaimer General This presentation is property of Docebo Inc. (the "Company", "Docebo", "us" or "we"). It cannot be circulated or forwarded without our consent. Any graphs, tables or other information demonstrating our historical performance or that of any other entity contained in this presentation are intended only to illustrate past performance and are not necessarily indicative of our or such entities ...

February 27, 2026 4Q and Full-Year 2025 Earnings Results Call © 2026 ANI Pharmaceuticals, Inc. 1 Disclaimers Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that are not historical facts, including statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are forward- l ...

Investor Presentation Q4 2025 Updated February 27, 2026 1 Forward-Looking Statements and Non-GAAP Financial Information This presentation contains statements about 1stdibs.com, Inc.'s (the "Company") future financial results, plans, and efforts to expand our market share that are "forward-looking statements" within the meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve substantial risks and uncertainties. Any statements cont ...